to leave his post as CEO of GE HealthCare to take the role of CEO at ABB. On July 17, 2008, GE HealthCare announced John Dineen had been chosen to replace outgoing CEO Joseph Hogan. Mr. Dineen had been head of GE's Transportation division since 2005. On March 24, 2010, GE HealthCare announced acquisition of MedPlexus. In late April, 2010, GE HealthCare announced it was investing €3 million in the Technology Research for Independent Living Centre (TRIL). The Irish centre seeks to enhance independence for elderly people through technological innovation. In July 2015, GE HealthCare partnered with the 2015 CrossFit Games to provide athletes with mobile imaging equipment. In January 2016, it was announced GE HealthCare's global headquarters will move to Chicago effective early 2016. In June 2017, GE announced Kieran Murphy as the new CEO of GE HealthCare, with former CEO John Flannery's appointment as CEO of GE. In April 2018, GE announced the sale of several healthcare information technology assets for $1.05 billion to Veritas Capital. In June 2018, GE announced plans to spin off GE HealthCare into its own company, representing the conglomerate's efforts to shrink and focus more on the aviation, power and renewable energy sectors. The plan was put on hold after selling the biopharma business to Danaher Corporation for $21.4 billion. In January 2020, GE announced Mahesh Palashikar As New President, CEO of its south Asia division. In November of the same year the business announced it would acquire Prismatic Sensors AB. In 2021, GE started a collaboration with Spectronic Medical to create AI-based software. In September the business announced it would acquire BK Medical from Altaris Capital Partners for $1.45 billion. On November 9, 2021, the company announced it would demerge into three investment-grade public companies, GE HealthCare being one of the three planned divestitures. The spin-off of GE HealthCare happened on 4 January 2023. In February 2023, it was announced GE HealthCare has acquired the San Mateo-headquartered AI medical technology manufacturer, Caption Health, for an undisclosed sum. Criticism Gadolinium-based contrast agents In 1994, GE HealthCare ignored advice of its safety experts to proactively restrict the use of its MRI contrast Omniscan and tried to conceal evidence of its risks by telling its researchers to "burn the data", as revealed during a trial opposing debilitated consumers due to its accumulation in multiple organs. In 2009, GE HealthCare sued for defamation a radiologist at